Berentzen-Group update – H1 2021

Berentzen published their H1 2021 report and it’s time to have a look how the company is managing the pandemic. (To learn more about the company please check my previous post or the companies website.) We can see that revenue

Read More Berentzen-Group update – H1 2021

Eckert & Ziegler AG

Eckert & Ziegler Group is one of the world’s largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The two business segments are: Medical

Read More Eckert & Ziegler AG

Price Earnings Valuation (P/E)

Price Earnings Valuation – Why it’s not good to use as isolated valuation approach Price earnings ratio (P/E) is a commonly used valuation metric. It is very simple to calculate and easily understood. Therefore, it is helpful to identify potential

Read More Price Earnings Valuation (P/E)

Fresenius SE – Update 30.04.2021

Following my recent post about Fresenius. I went deeper into their financials trying to understand why the share price dropped over the last years. In 2017 they acquired a Spanish hospital group (Grupo Hospitalario Quirónsalud) which increased Fresenius’s debt by

Read More Fresenius SE – Update 30.04.2021

Archer Daniels Midland Co. – Good Value and Attractive Dividends

I decided to purchase another stock during the last week’s downturn which I constantly had on my watchlist: Archer Daniels Midland Company (ADM). I had purchased some shares during the great depression in 2008 or 2009 because I liked their low

Read More Archer Daniels Midland Co. – Good Value and Attractive Dividends

Last two weeks and recent purchases

Wow! What an exciting start into 2016. Falling indices and high volatility. The Dow Jones is down 6%, S&P – 5.97%, Nasdaq – 7.84%, DAX -8.83%, Nikkei -9.42% and Shanghai -15.02%. Many commodities also dropped with oil down nearly 20%

Read More Last two weeks and recent purchases